What is the interpretation of a thyroid function test showing a Thyroid-Stimulating Hormone (TSH) level of 2.080 milliunits per liter (mU/L) and a Thyroxine (T4) level of 0.79 nanograms per deciliter (ng/dL) in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of TSH 2.080 mU/L and T4 0.79 ng/dL

These results indicate normal thyroid function (euthyroidism), as the TSH falls within the standard reference range of 0.45-4.12 mU/L, though the T4 value requires clarification of units and reference range to fully assess. 1, 2

Primary Assessment

TSH Interpretation:

  • A TSH of 2.080 mU/L is solidly within the normal reference range (0.45-4.12 mU/L for adults under 60 years) 1, 2
  • This value is close to the geometric mean TSH of 1.4 mU/L observed in disease-free populations, indicating optimal thyroid function 3
  • Values below 0.1 mU/L are considered low and values above 6.5 mU/L (or 4.5 mU/L by some definitions) are considered elevated 1

T4 Interpretation - Critical Caveat:

  • The T4 value of 0.79 ng/dL appears abnormally low if this represents total T4 (normal range typically 5-12 mcg/dL or 50-120 ng/mL) 4
  • This likely represents a unit conversion issue or the value may actually be free T4 in different units 5
  • If this is free T4 measured in ng/dL, it would need comparison to the laboratory's specific reference range (typically 0.8-1.8 ng/dL or 10-23 pmol/L) 5, 4

Clinical Significance

Normal TSH with Potentially Low T4:

  • When TSH is normal but T4 appears low, consider: 5, 4
    • Laboratory error or unit misinterpretation (most likely in this case)
    • Central (secondary) hypothyroidism - where pituitary dysfunction causes inappropriately normal TSH despite low thyroid hormone 5, 4
    • Non-thyroidal illness affecting T4 levels while TSH remains normal 1

If Results Are Accurate:

  • A normal TSH with truly low T4 would be highly unusual and warrants investigation for central hypothyroidism, particularly if the patient has symptoms of hypothyroidism (fatigue, weight gain, cold intolerance) or history of pituitary/hypothalamic disease 5, 4
  • In central hypothyroidism, TSH is diagnostically misleading and free T4 should be measured directly 5

Recommended Next Steps

Immediate Actions:

  • Verify the T4 units and reference range with the laboratory - this is the most critical step 5
  • If T4 is truly low with normal TSH, measure free T4 to clarify thyroid status 1, 5
  • Assess for symptoms of thyroid dysfunction (fatigue, weight changes, temperature intolerance, cognitive changes) 1

If Patient is Asymptomatic with Confirmed Normal Values:

  • No treatment or further testing is needed 1
  • Routine screening intervals are not required unless symptoms develop or risk factors emerge 3

If Central Hypothyroidism is Suspected:

  • Evaluate other pituitary hormones, especially the hypothalamic-pituitary-adrenal axis, as hypocortisolism must be corrected before initiating thyroid hormone replacement to avoid precipitating adrenal crisis 4, 3

Important Clinical Caveats

  • TSH values can be transiently affected by acute illness, recent iodine exposure, certain medications, or recovery from thyroiditis 1, 3
  • Each individual has a unique thyroid function "set point" - a test result within laboratory reference limits may not be normal for a specific individual if their baseline differs significantly 6
  • When used for screening in primary care populations, TSH has lower positive predictive value than in specialty settings, and interpretation can be complicated by underlying illness or frailty 1
  • The distinction between normal and abnormal thyroid function can be somewhat arbitrary, as individual reference ranges are much narrower than population-based laboratory ranges 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[The interpretation of the thyroid stimulating hormone (TSH) assay].

Nederlands tijdschrift voor geneeskunde, 2003

Guideline

Initial Treatment for Elevated TSH

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Thyroid Function Investigation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the management plan for a 33-year-old African American (AA) female with a low Thyroid-Stimulating Hormone (TSH) level and normal free Thyroxine (T4) level?
What is the appropriate management for a patient with hypothyroidism indicators, vitamin D insufficiency, potential dehydration, and mildly elevated bilirubin level?
What is the management approach for a 19-year-old female with a slightly low Thyroid-Stimulating Hormone (TSH) level and normal free thyroxine (FT4) level, without symptoms?
What is the management plan for a 29-year-old female with no history of thyroid disease, presenting with a suppressed Thyroid-Stimulating Hormone (TSH) level and normal free Thyroxine (T4) level?
What is the appropriate management for a 16-year-old male with a slightly low Thyroid-Stimulating Hormone (TSH) level, normal Triiodothyronine (T3) and Thyroxine (T4) levels, and a Thyroid Peroxidase (TPO) level of 1?
What type of drug is Mounjaro (tirzepatide), a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, for an adult patient with type 2 diabetes?
What is the best treatment approach for a 33-year-old female patient with a history of untreated Attention Deficit Hyperactivity Disorder (ADHD) who suffered a concussion 7 months ago, currently experiencing headaches, neck and shoulder pain, executive dysfunction, memory issues, difficulty with concentration and focus, emotional reactivity, and bladder control problems, and is currently being treated with Qelbree (viloxazine), Wellbutrin XL (bupropion), and Prozac (fluoxetine), and has undergone vestibular physical therapy and trigger point injections?
Does treatment with Rituximab (rituximab) within weeks post kidney transplant interfere with long-term graft success in kidney transplant patients?
What is the timing for the next dose of tirzepatide (glucagon-like peptide-1 receptor agonist) in an adult patient with type 2 diabetes and no significant renal or hepatic impairment?
Is it safe to use non-FDA (Food and Drug Administration) approved peptides in patients with a history of growth hormone deficiency or cancer?
How to manage atrial fibrillation in a patient with acute kidney injury (AKI) and reduced ejection fraction (EF) of 40%?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.